V011-2630 Screening compound: 4-(3-FLUOROPHENYL)-2-(3-METHYLPHENYL)-N6-[2-(MORPHOLIN-4-YL)ETHYL]-2H-PYRAZOLO[3,4-D]PYRIMIDINE-3,6-DIAMINE

V011-2630 Screening compound: 4-(3-FLUOROPHENYL)-2-(3-METHYLPHENYL)-N6-[2-(MORPHOLIN-4-YL)ETHYL]-2H-PYRAZOLO[3,4-D]PYRIMIDINE-3,6-DIAMINE
V011-2630 Screening compound: 4-(3-FLUOROPHENYL)-2-(3-METHYLPHENYL)-N6-[2-(MORPHOLIN-4-YL)ETHYL]-2H-PYRAZOLO[3,4-D]PYRIMIDINE-3,6-DIAMINE alternative view

Chemical Structure Depiction of ChemDiv screening compound V011-2630
4-(3-FLUOROPHENYL)-2-(3-METHYLPHENYL)-N6-[2-(MORPHOLIN-4-YL)ETHYL]-2H-PYRAZOLO[3,4-D]PYRIMIDINE-3,6-DIAMINE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V011-2630

Molecular Formula

C24H26FN7O (C24 H26 FN7 O)

Compound Name

4-(3-FLUOROPHENYL)-2-(3-METHYLPHENYL)-N6-[2-(MORPHOLIN-4-YL)ETHYL]-2H-PYRAZOLO[3,4-D]PYRIMIDINE-3,6-DIAMINE

IUPAC name

n/a

SMILES

Cc1cccc(-n(c(N)c23)nc3nc(NCCN3CCOCC3)nc2-c2cccc(F)c2)c1

InChI

InChI=1S/C24H26FN7O/c1-16-4-2-7-19(14-16)32-22(26)20-21(17-5-3-6-18(25)15-17)28-24(29-23(20)30-32)27-8-9-31-10-12-33-13-11-31/h2-7,14-15H,8-13,26H2,1H3,(H,27,29,30)

InChI Key

HDYQDQPHRWAMTN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14249516

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

447.52

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.775

Distribution Coefficient, logD

3.686

Water Solubility, LogSw

-4.17

Polar Surface Area

76.543

Acid Dissociation Constant (pKa)

17.85

Base Dissociation Constant (pKb)

6.76

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

29.20

V011-2630 in Drug Discovery

Included in Screening Libraries

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V011-2630 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V011-2630?
Check Price and Availability of V011-2630, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V011-2630 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V011-2630
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V011-2630
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V011-2630 available by request